-
Stocks to Watch: National Oilwell Varco (NYSE:NOV), Genworth Financial (NYSE:GNW), CorMedix (NYSEMKT:CRMD), Stryker (NYSE:SYK), Espey Mfg. & Electronics (NYSEMKT:ESP)
National Oilwell Varco, Inc. (NYSE:NOV) declared a quarterly dividend, which is scheduled for Friday, December 19th. Investors of record on Friday, December 5th will be given a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Wednesday, December…
-
Healthcare Gainers: Geron Corporation (NASDAQ:GERN), Neostem (NASDAQ:NBS), OXiGENE (NASDAQ:OXGN), CorMedix (NYSEMKT:CRMD), Coronado Biosciences (NASDAQ:CNDO)
Geron Corporation (NASDAQ:GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ) for the development and commercialization of its sole pipeline candidate, imetelstat. Geron Corporation (NASDAQ:GERN) in last trading activity advanced 19.48% to close at $2.76.…
-
Biotech Gainers: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), CorMedix (NYSEMKT:CRMD), Akebia Therapeutics (NASDAQ:AKBA), Vital Therapies (NASDAQ:VTL), ProQR Therapeutics N.V. (NASDAQ:PRQR)
Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) on Nov. 11 announced it has received a $1.1 million refund of the previously paid Prescription Drug User Fee Act (PDUFA) filing fee related to the granting of orphan drug status of Lymphoseek® (technetium Tc 99m tilmanocept) injection in head and neck cancers. Lymphoseek was granted Orphan Drug Designation by the…
-
Active Watch List: Mondelez International (NASDAQ:MDLZ), Eldorado Gold Corp. (NYSE:EGO), Walgreen Co. (NYSE:WAG), CorMedix (NYSEMKT:CRMD), Columbia Banking System Inc. (NASDAQ:COLB)
Mondelez International Inc. (NASDAQ:MDLZ) plans to invest $50m (£30m) in its Banbury factory in the UK to build two new lines that will manufacture Tassimo beverage capsules. Mondelez International, Inc. (NASDAQ:MDLZ) in last trading activity fell -0.21% to close at $37.76. Company weekly performance is 7.09% while its quarterly performance stands at 6.04%. Mondelez International,…
-
Today’s Stocks: Cabot Oil & Gas Corporation (NYSE:COG), XOMA Corporation (NASDAQ:XOMA), Roper Industries Inc. (NYSE:ROP), CorMedix (NYSEMKT:CRMD), Marathon Oil Corporation (NYSE:MRO)
Cabot Oil & Gas Corporation (NYSE:COG) announced a cash dividend. Payment of $0.02 per share is scheduled to be paid on November 18, 2014. Shareholders who purchased COG stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 5th quarter that COG has paid the same dividend. At the…
-
Investors Are Watching: American International Group(NYSE:AIG), Alcoa Inc. (NYSE:AA), ORBCOMM(NASDAQ:ORBC), The Marcus Corporation (NYSE:MCS), CorMedix(NYSEMKT: CRMD)
American International Group, Inc. (NYSE:AIG) agreed to pay a $35 million penalty to resolve a New York State probe into unlicensed insurance sales by former units. American International Group, Inc. (NYSE:AIG) in last trading activity moved up 1.21% to close at $53.57. Company weekly performance is 2.70% while its quarterly performance stands at 1.96%. American…
-
Biotech Insider Buying: Arrowhead Research Corp. (NASDAQ:ARWR), Vital Therapies(NASDAQ:VTL), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), RXi Pharmaceuticals Corporation (NASDAQ:RXII), CorMedix(NYSEMKT:CRMD)
Arrowhead Research Corp (NASDAQ:ARWR) CEO Christopher Richard Anzalone acquired 16,000 shares of Arrowhead Research Corp stock on the open market in a transaction that occurred on Wednesday, October 15th. The stock was purchased at an average cost of $6.32 per share, for a total transaction of $101,120.00. Following the completion of the purchase, the chief…
-
Hot Watch List : CorMedix (NYSEMKT:CRMD), Coronado Biosciences (NASDAQ:CNDO), International Bancshares (NASDAQ:IBOC), Cheniere Energy Partners LP (NYSEMKT:CQH), Shoe Carnival (NASDAQ:SCVL)
A number of analysts have recently weighed in on CRMD shares. Analysts at Zacks downgraded shares of CorMedix , Inc. (NYSEMKT:CRMD) to a “neutral” rating in a research note on Monday, July 28th. They now have a $2.20 price target on the stock. CorMedix, Inc. (NYSEMKT:CRMD) in last trading activity remains unchanged to close at…